title: mTOR inhibitor therapy for patients with carcinoid.
authors: Institute of Pathology, Università Cattolica-Policlinico A. Gemelli, 00168 Rome, Italy. Electronic address: guido.rindi@rm.unicatt.it.
authors: Guido
authors: G
authors: Rindi
authors: Neuroendocrine Tumour Unit, Centre for Gastroenterology, Royal Free Hospital, London, UK.
authors: Martyn
authors: M
authors: Caplin
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D002276:Carcinoid Tumor / Q000188:drug therapy*; D000068338:Everolimus; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy*; D015282:Octreotide / Q000627:therapeutic use*; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D007166:Immunosuppressive Agents; D000068338:Everolimus; D015282:Octreotide; D020123:Sirolimus